Goodrich Katherine 4
4 · Tarsus Pharmaceuticals, Inc. · Filed Jun 16, 2025
Insider Transaction Report
Form 4
Goodrich Katherine
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-12+4,540→ 4,540 totalExercise: $40.95Exp: 2035-06-11→ Common Stock (4,540 underlying) - Award
Restricted Stock Units
2025-06-12+2,954→ 2,954 total→ Common Stock (2,954 underlying)
Footnotes (3)
- [F1]Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
- [F3]RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.